Abstract
Background A clinical decision support system (CDSS) linked to the computerized physician order entry may help improve prescription appropriateness in inpatients with renal insufficiency. Objective To evaluate the impact on prescription appropriateness of a CDSS prescriber alert for 85 drugs in renal failure patients. Setting Before-after study in a 975-bed academic hospital. Method Prescriptions of patients with renal failure were reviewed during two comparable periods of 6 days each, before and after the implementation of the CDSS (September 2009 and 2010). Main outcome measure The proportion of inappropriate dosages of 85 drugs included in the CDSS was compared in the pre- and post-implementation group. Results Six hundred and fifteen patients were included in the study (301 in pre- and 314 in post-implementation periods). In the pre- and post-implementation period, respectively 2882 and 3485 prescriptions were evaluated, of which 14.9 and 16.6% triggered an alert. Among these, the dosage was inappropriate in respectively 25.4 and 24.6% of prescriptions in the pre- and post-implementation periods (OR 0.97; 95% CI 0.72–1.29). The most frequently involved drugs were paracetamol, perindopril, tramadol and allopurinol. Conclusion The implementation of a CDSS did not significantly reduce the proportion of inappropriate drug dosages in patients with renal failure. Further research is required to investigate the reasons why prescribers override alerts. Collaboration with clinical pharmacists might improve compliance with the CDSS recommendations.
Similar content being viewed by others
References
Munar MY, Singh H. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Phys. 2007;75(10):1487–96.
Breton G, Froissart M, Janus N, Launay-Vacher V, Berr C, Tzourio C, et al. Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function—the Three-City population-based study. Nephrol Dial Transpl. 2011;26(9):2852–9.
Blix HS, Viktil KK, Moger TA, Reikvam A. Use of renal risk drugs in hospitalized patients with impaired renal function—an underestimated problem? Nephrol Dial Transpl. 2006;21(11):3164–71.
Roberts GW, Farmer CJ, Cheney PC, Govis SM, Belcher TW, Walsh SA, et al. Clinical decision support implemented with academic detailing improves prescribing of key renally cleared drugs in the hospital setting. J Am Med Inf Assoc (JAMIA). 2010;17(3):308–12.
Hug BL, Witkowski DJ, Sox CM, Keohane CA, Seger DL, Yoon C, et al. Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney. Kidney Int. 2009;76(11):1192–8.
Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J. 2003;33(1–2):10–3.
Salomon L, Levu S, Deray G, Launay-Vacher V, Brucker G, Ravaud P. Assessing residents’ prescribing behavior in renal impairment. Int J Qual Health Care. 2003;15(3):235–40.
Salomon L, Deray G, Jaudon MC, Chebassier C, Bossi P, Launay-Vacher V, et al. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care. 2003;15(4):331–5.
van Dijk EA, Drabbe NR, Kruijtbosch M, De Smet PA. Drug dosage adjustments according to renal function at hospital discharge. Ann Pharmacother. 2006;40(7–8):1254–60.
Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, et al. Guided medication dosing for inpatients with renal insufficiency. J Am Med Assoc (JAMA). 2001;86(22):2839–44.
Aronoff GR, Aronoff JR. Drug prescribing in kidney disease: can’t we do better? Am J Kidney Dis. 2014;63(3):382–3.
Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol. 2014;12:35.
Cabello-Muriel A, Gascon-Canovas JJ, Urbieta-Sanz E, Iniesta-Navalon C. Effectiveness of pharmacist intervention in patients with chronic kidney disease. Int J Clin Pharm. 2014;36(5):896–903.
Nuckols TKS-SC, Smith-Spangler C, Morton SC, Asch SM, Patel VM, Anderson LJ, et al. The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis. Syst Rev. 2014;4(3):56.
Terrell KM, Perkins AJ, Hui SL, Callahan CM, Dexter PR, Miller DK. Computerized decision support for medication dosing in renal insufficiency: a randomized, controlled trial. Ann Emerg Med. 2010;56(6):623–9.
Sellier E, Colombet I, Sabatier B, Breton G, Nies J, Zapletal E, et al. Effect of alerts for drug dosage adjustment in inpatients with renal insufficiency. J Am Med Inf Assoc (JAMIA). 2009;16(2):203–10. https://doi.org/10.1197/jamia.m2805.
SPC. Summary of product characteristics. www.fagg-afmpsbe. Accessed 15 May 2017.
Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA et al. Drug prescribing in renal failure, dosing guidelines for adults. American College of Physicians. 2007. ISBN: 978-1-930513-76-1.
Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug information handbook. 2009–2010. ISBN 13: 978-1-591952-54-1.
Pai MP. Estimating the glomerular filtration rate in obese adult patients for drug dosing. Adv Chronic Kidney Dis. 2010;17(5):e53–62.
Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis. 2005;46(2):233–41.
Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and cockcroft-gault equations for estimating renal function. J Am Soc Nephrol. 2005;16:763–73.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–54.
Helou R. Should we continue to use the Cockcroft–Gault formula? Nephron Clin Pract. 2010;116(3):c172–86.
Stevens LA, Nolin TD, Richardson MM, Feldman HI, Lewis JB, Rodby R, et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis. 2009;54(1):33–42.
Gill J, Malyuk R, Djurdjev O, Levin A. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group—a cautionary tale. Nephrol Dial Transpl. 2007;22(10):2894–9.
Van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inf Assoc (JAMIA). 2006;13:138–47.
Scheepers-Hoeks AM, Grouls RJ, Neef C, Korsten HH. Strategy for implementation and first results of advanced clinical decision support in hospital pharmacy practice. Stud Health Technol Inf. 2009;148:142–8.
Judge J, Field TS, DeFlorio M, Laprino J, Auger J, Rochon P, et al. Prescribers’ responses to alerts during medication ordering in the long term care setting. J Am Med Inf Assoc (JAMIA). 2006;13(4):385–90.
Czock D, Konias M, Seidling HM, Kaltschmidt J, Schwenger V, Zeier M, et al. Tailoring of alerts substantially reduces the alert burden in computerized clinical decision support for drugs that should be avoided in patients with renal disease. J Am Med Inf Assoc (JAMIA). 2015;22(4):881–7.
Cho I, Slight SP, Nanji KC, Seger DL, Maniam N, Dykes PC, et al. Understanding physicians’ behavior toward alerts about nephrotoxic medications in outpatients: a cross-sectional analysis. BMC Nephrol. 2014;15:200.
Brown C, Hofer T, Johal A, Thomson R, Nicholl J, Franklin B, et al. An epistemology of patient safety research: a framework for study design and interpretation. Part 2. Study design. Qual Saf Health Care. 2008;17:163–9.
Bertrand J, Genevay S, Saudan P. Traitement de la goutte chez l’insuffisant rénal. Rev Med Suisse. 2011;7:483–9.
Melton BL, Zillich AJ, Russell SA, Weiner M, McManus MS, Spina JR, et al. Reducing prescribing errors through creatinine clearance alert redesign. Am J Med. 2015;128(10):1117–25.
Such Díaz A, Saez de la Fuente J, Esteva L, Alañón Pardo A, Barrueco N, Esteban C et al. Drug prescribing in patients with renal impairment optimized by a computer-based, semi-automated system. Int J Clin Pharm. 2013;35(6):1170–7.
Cornu P, Steurbaut S, Sostaric S, Mrhar A, Dupont AG. Performance of a clinical decision support system and of clinical pharmacists in preventing drug-drug interactions on a geriatric ward. Int J Clin Pharm. 2014;36(3):519–25.
Spinewine A, Dhillon S, Mallet L, Tulkens PM, Wilmotte L, Swine C. Implementation of ward-based clinical pharmacy services in Belgium—description of the impact on a geriatric unit. Ann Pharmacother. 2006;40(4):720–8.
Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M. Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med. 2001;16(6):369–75.
Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72(3):247–59.
Acknowledgements
The authors would like to thank M. Demey (IT department) for the development of the CDSS at the Cliniques universitaires Saint-Luc, Brussels, S. Thevelin and V. Mohymont.
Funding
No specific funding was received for this research.
Conflicts of interest
None. The authors have no conflicts of interest that are directly relevant to the content of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Desmedt, S., Spinewine, A., Jadoul, M. et al. Impact of a clinical decision support system for drug dosage in patients with renal failure. Int J Clin Pharm 40, 1225–1233 (2018). https://doi.org/10.1007/s11096-018-0612-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-018-0612-1